U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 1484

1.
Low-Grade Primary Splenic CD10-Positive Small B-Cell Lymphoma/Follicular Lymphoma
Rami Abdulbaki, Parastou Tizro, Victor E. Nava, Maria Gomes da Silva, João L. Ascensão
Curr Oncol. 2021 Dec; 28(6): 4821–4831. Published online 2021 Nov 18. doi: 10.3390/curroncol28060407
PMCID:
PMC8628768
AbstractArticlePDF–3.0M
2.
Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation
Brendan P. Hodkinson, Michael Schaffer, Joshua D. Brody, Wojciech Jurczak, Cecilia Carpio, Dina Ben-Yehuda, Irit Avivi, Ann Forslund, Muhit Özcan, John Alvarez, Rob Ceulemans, Nele Fourneau, Anas Younes, Sriram Balasubramanian
Transl Oncol. 2021 Jan; 14(1): 100977. Published online 2020 Dec 6. doi: 10.1016/j.tranon.2020.100977
PMCID:
PMC7723809
AbstractArticlePDF–823K
3.
Efficacy and safety of MIL62, a novel glycoengineered type Ⅱ anti-CD20 monoclonal antibody, combined with lenalidomide in patients with relapsed/refractory follicular lymphoma or marginal zone lymphoma: a multicentre, single-arm, phase 1b/2 trial
Yuankai Shi, Keshu Zhou, Hui Zhou, Yan Qin, Hongmei Jing, Ying Xiang, Zhao Wang, Zhen Wang, Aimin Zang, Ou Bai, Zhenyu Li, Huilai Zhang, Yongping Song, Jinjin Liang, Min Wei
eClinicalMedicine. 2024 Jul; 73: 102702. Published online 2024 Jun 20. doi: 10.1016/j.eclinm.2024.102702
PMCID:
PMC11245993
AbstractArticlePDF–1020K
4.
Long-Term Remission with Novel Combined Immune-Targeted Treatment for Histiocytic Sarcoma Accompanied by Follicular Lymphoma: Case Report and Literature Review
Minyue Zhang, Fei Xiao, Jianchen Fang, Zebing Liu, Yanying Shen, Di Zhu, Yiwei Zhang, Jian Hou, Honghui Huang
Int J Mol Sci. 2024 Jul; 25(13): 7293. Published online 2024 Jul 2. doi: 10.3390/ijms25137293
PMCID:
PMC11242306
AbstractArticlePDF–3.9M
5.
Prolonged water-only fasting in the management of low-grade follicular lymphoma: a case series
Sahmla Gabriel, Toshia R. Myers, Natasha Thompson, Alan C. Goldhamer
J Med Case Rep. 2024; 18: 302. Published online 2024 Jul 3. doi: 10.1186/s13256-024-04609-w
PMCID:
PMC11221076
AbstractArticlePDF–1001K
6.
Matching-adjusted indirect comparison from the Lymphoma Epidemiology of Outcomes Consortium for Real World Evidence (LEO CReWE) study to a clinical trial of mosunetuzumab in relapsed or refractory follicular lymphoma
Matthew J. Maurer, Carla Casulo, Melissa C. Larson, Thomas M. Habermann, Izidore S. Lossos, Yucai Wang, Loretta J. Nastoupil, Christopher Strouse, Dai Chihara, Peter Martin, Jonathon B. Cohen, Brad S. Kahl, W. Richard Burack, Jean L. Koff, Yong Mun, Anthony Masaquel, Mei Wu, Michael C. Wei, Ashwini Shewade, Jia Li, James R. Cerhan, Brian K. Link, Christopher R. Flowers
Haematologica. 2024 Jul 1; 109(7): 2177–2185. Published online 2023 Nov 30. doi: 10.3324/haematol.2023.283737
PMCID:
PMC11215382
AbstractArticlePDF–2.3M
7.
Chylothorax as Initial Presentation of Follicular Lymphoma: A Case Report and Literature Search
Gi Eun Kim, Yousif Khaled, Saleh Mahmoud, Amin Ur Rehman
Case Rep Hematol. 2024; 2024: 7985228. Published online 2024 Jun 6. doi: 10.1155/2024/7985228
PMCID:
PMC11208796
AbstractArticlePDF–430K
8.
Transformation of t(14;18)-negative follicular lymphoma to plasmablastic lymphoma: a case report with analysis of genetic evolution
Sojung Lim, Jiwon Koh, Jeong Mo Bae, Hongseok Yun, Cheol Lee, Jin Ho Paik, Tae Min Kim, Yoon Kyung Jeon
Diagn Pathol. 2024; 19: 86. Published online 2024 Jun 22. doi: 10.1186/s13000-024-01512-2
PMCID:
PMC11193252
AbstractArticlePDF–3.0M
9.
The treatment of follicular lymphoma with CD19-directed chimeric antigen receptor T-cell therapy
Ryan Jacobs, Caron Jacobson
Front Oncol. 2024; 14: 1384600. Published online 2024 Jun 5. doi: 10.3389/fonc.2024.1384600
PMCID:
PMC11188288
AbstractArticlePDF–428K
10.
Treatment sequencing and impact of number of treatment lines on survival in follicular lymphoma: A national population‐based study
Tove Wästerlid, Caroline E. Dietrich, Anna Oksanen, Linn Deleskog Spångberg, Björn E Wahlin, Gunilla Enblad, Per‐Ola Andersson, Eva Kimby, Karin E. Smedby
EJHaem. 2024 Jun; 5(3): 516–526. Published online 2024 Apr 28. doi: 10.1002/jha2.904
PMCID:
PMC11182409
AbstractArticlePDF–2.3M
11.
Comparison of gene expression profiles of lymphoma cell lines from transformed follicular lymphoma, Burkitt's lymphoma and de novo diffuse large B‐cell lymphoma
Yoshitomo Maesako, Takashi Uchiyama, Hitoshi Ohno
Cancer Sci. 2003 Sep; 94(9): 774–781. Published online 2005 Aug 19. doi: 10.1111/j.1349-7006.2003.tb01518.x
PMCID:
PMC11160262
AbstractArticlePDF–872K
12.
Follicular lymphoma subgrouping by fluorescence in situ hybridization analysis
Naohiro Sekiguchi, Yukio Kobayashi, Yukiko Yokota, Shigeru Kusumoto, Kazuki Tanimoto, Takashi Watanabe, Yoshihiro Matsuno, Kensei Tobinai
Cancer Sci. 2005 Feb; 96(2): 77–82. Published online 2005 Feb 21. doi: 10.1111/j.1349-7006.2005.00014.x
PMCID:
PMC11159974
AbstractArticlePDF–138K
13.
Diffuse large B‐cell lymphoma after transformation from low‐grade follicular lymphoma: morphological, immunohistochemical, and FISH analyses
Akiko Miyagi Maeshima, Mutsuko Omatsu, Junko Nomoto, Dai Maruyama, Sung‐Won Kim, Takashi Watanabe, Yukio Kobayashi, Kensei Tobinai, Yoshihiro Matsuno
Cancer Sci. 2008 Sep; 99(9): 1760–1768. Published online 2008 Jun 28. doi: 10.1111/j.1349-7006.2008.00873.x
PMCID:
PMC11159886
AbstractArticlePDF–345K
14.
Phase I study of inotuzumab ozogamicin (CMC‐544) in Japanese patients with follicular lymphoma pretreated with rituximab‐based therapy
Michinori Ogura, Kensei Tobinai, Kiyohiko Hatake, Toshiki Uchida, Masanobu Kasai, Takashi Oyama, Tatsuya Suzuki, Yukio Kobayashi, Takashi Watanabe, Teruhisa Azuma, Masakazu Mori, Yasuhito Terui, Masahiro Yokoyama, Yuko Mishima, Shunji Takahashi, Chiho Ono, Junko Ohata
Cancer Sci. 2010 Aug; 101(8): 1840–1845. Published online 2010 Apr 23. doi: 10.1111/j.1349-7006.2010.01601.x
PMCID:
PMC11159835
AbstractArticlePDF–157K
15.
Comparison of genetic aberrations in CD10+ diffused large B‐cell lymphoma and follicular lymphoma by comparative genomic hybridization and tissue‐fluorescence in situ hybridization
Xiaohua Zhang, Sivasundaram Karnan, Hiroyuki Tagawa, Ritsuro Suzuki, Shinobu Tsuzuki, Yoshitaka Hosokawa, Yasuo Morishima, Shigeo Nakamura, Masao Seto
Cancer Sci. 2004 Oct; 95(10): 809–814. Published online 2005 Aug 19. doi: 10.1111/j.1349-7006.2004.tb02186.x
PMCID:
PMC11158964
AbstractArticlePDF–948K
16.
Cost-effectiveness of treating relapsed or refractory 3L+ follicular lymphoma with axicabtagene ciloleucel vs mosunetuzumab in the United States
Olalekan O. Oluwole, Markqayne D. Ray, Richard M. Zur, Cheryl P. Ferrufino, Brett Doble, Anik R. Patel, S. Pinar Bilir
Front Immunol. 2024; 15: 1393939. Published online 2024 May 24. doi: 10.3389/fimmu.2024.1393939
PMCID:
PMC11157123
AbstractArticlePDF–1.6M
17.
Ayurveda Rasayana Therapy (ART) leads to tumor regression and increased survival in chemo‐intolerance high‐grade stage IV follicular lymphoma: A case study
Yogesh Narayan Bendale, Poonam Birari‐Gawande, Anandrao Patil, Avinash Kadam
Clin Case Rep. 2024 Jun; 12(6): e8076. Published online 2024 May 30. doi: 10.1002/ccr3.8076
PMCID:
PMC11139640
AbstractArticlePDF–801K
18.
Follicular lymphoma regulatory T-cell origin and function
Stéphane Rodriguez, Mehdi Alizadeh, Claire Lamaison, Alexis Saintamand, Céline Monvoisin, Rachel Jean, Laurent Deleurme, Jose Ignacio Martin-Subero, Céline Pangault, Michel Cogné, Patricia Amé-Thomas, Karin Tarte
Front Immunol. 2024; 15: 1391404. Published online 2024 May 10. doi: 10.3389/fimmu.2024.1391404
Correction in:
Front Immunol. 2024; 15: 1472373.
PMCID:
PMC11116630
AbstractArticlePDF–2.4M
19.
Thyroid papillary carcinoma combined with primary follicular lymphoma: a case report
Ting Xu, Li Wu, Hua Ye, Shuai Luo, Jinjing Wang
Diagn Pathol. 2024; 19: 69. Published online 2024 May 21. doi: 10.1186/s13000-024-01495-0
PMCID:
PMC11107012
AbstractArticlePDF–1.9M
20.
A 24-month updated analysis of the comparative effectiveness of ZUMA-5 (axi-cel) vs. SCHOLAR-5 external control in relapsed/refractory follicular lymphoma
M Lia Palomba, Paola Ghione, Anik R Patel, Myrna Nahas, Sara Beygi, Anthony J Hatswell, Steve Kanters, Eve H. Limbrick-Oldfield, Sally W Wade, Markqayne D Ray, Jessica Owen, Sattva S Neelapu, John Gribben, John Radford, Sabela Bobillo
Expert Rev Anticancer Ther. Author manuscript; available in PMC 2024 May 20.
Published in final edited form as: Expert Rev Anticancer Ther. 2023 Feb; 23(2): 199–206. Published online 2023 Feb 10. doi: 10.1080/14737140.2023.2171994
PMCID:
PMC11104735
AbstractArticlePDF–599K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center